Elicio Therapeutics (ELTX) Assets Average (2021 - 2026)

Elicio Therapeutics (ELTX) has 6 years of Assets Average data on file, last reported at $24.3 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 13.85% year-over-year to $24.3 million; the trailing twelve-month figure through Mar 2026 stood at $24.3 million (down 13.85% YoY), and the FY2025 full-year result was $27.0 million, down 2.32% from the prior year.
• Assets Average for Q1 2026 stood at $24.3 million, down from $27.1 million in the prior quarter.
• Across five years, Assets Average topped out at $88.9 million in Q1 2022 and bottomed at $20.1 million in Q2 2024.
• The 5-year median for Assets Average is $29.1 million (2023), against an average of $38.3 million.
• The widest annual swing landed in 2023, when Assets Average sank 63.76%; it then surged 43.44% in 2025.
• A 5-year view of Assets Average shows it stood at $42.0 million in 2022, then sank by 30.78% to $29.1 million in 2023, then advanced by 14.51% to $33.3 million in 2024, then decreased by 18.66% to $27.1 million in 2025, then declined by 10.33% to $24.3 million in 2026.
• The last three Assets Average figures came in at $24.3 million (Q1 2026), $27.1 million (Q4 2025), and $28.9 million (Q3 2025), per Business Quant data.

Peer Comparison